Skip to search formSkip to main contentSkip to account menu

ioversol

Known as: N,N'-Bis (2,3-dihydroxypropyl)-5-[N-(2-hydroxyethyl) -glycolamido] -2,4,6-triiodoisophthalamide, ioversol [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Contrast MediaTriiodobenzoic Acids
Hypersensitivity

Narrower (1)

Optiray

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Low osmolar contrast medium induces cellular injury and disruption of calcium homeostasis in rat glomerular endothelial cells in vitro.
2003
2003
Does Continuous Venovenous Hemodiafiltration Concomitant with Radiological Procedures Provide a Significant and Safe Removal of the Iodinated Contrast Ioversol?
Background: The purpose of our study was to investigate whether continuous venovenous hemodiafiltration (CVVHDF) concomitant with… 
2002
2002
Measuring portal venous perfusion with contrast-enhanced CT: comparison of direct and indirect methods.
2000
2000
Hypersensitivity reaction to ioversol
References 1. Primary immunode®ciency diseases. Report of a WHO scienti®c group. Clin Exp Immunol 1997;109 Suppl 1. 2. SNELLER MC… 
1999
1999
Spiral CT angiography of the abdominal aorta. Comparison of iodixanol and ioversol.
RATIONALE AND OBJECTIVES Enhancement characteristics of a nonionic, dimeric, isotonic contrast medium (iodixanol [Visipaque… 
1993
1993
Ionic contrast agent-mediated endothelial injury causes increased platelet deposition to vascular surfaces.
1992
1992
Effect of viscosity and iodine concentration of nonionic radiographic contrast media on coronary arteriography in patients.
1991
1991
Molecular features necessary for the uptake of diamines and related compounds by the polyamine receptor of rat lung slices.
1989
1989
Acute and Subacute Toxicity Studies of Ioversol in Experimental Animals
The authors examined the acute and subacute toxicity of the low-osmolality nonionic radiographic contrast agent, ioversol. The… 
1955
1955
WIN 8077 in treatment of myasthenia gravis; use of N,N'-bis (2-diethylaminoethyl) oxamide bis-2-chlorobenzyl chloride in fifty patients.
The treatment of patients with myasthenia gravis prior to the year 1934 was ineffective in most cases, with a mortality rate… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)